Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study.

The journal of prevention of Alzheimer's disease·2026
Same author

Transcending genome-wide association studies to create useful multi-omic views of glaucoma.

Progress in retinal and eye research·2026
Same author

The Future of Glaucoma: Data, AI, and Precision Medicine for Patient-Centered Care.

Journal of glaucoma·2026
Same author

A Primary Open-Angle Glaucoma Locus Near Transcription Factor <i>PRRX1</i> Identified in the Million Veteran Program.

Ophthalmology science·2026
Same author

Primary Open Angle Glaucoma Polygenic Risk Score is Associated with Disease Progression.

Ophthalmology. Glaucoma·2026
Same author

Pre-diagnostic plasma endogenous steroids and the risk of exfoliation glaucoma.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jun 20, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Hyphema following selective laser trabeculoplasty.

Douglas J Rhee1, Omar Krad, Louis R Pasquale

  • 1Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA.

Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye
|September 24, 2009
PubMed
Summary

Selective laser trabeculoplasty effectively lowers eye pressure for open-angle glaucoma. A rare case of hyphema occurred post-procedure, possibly linked to nonsteroidal anti-inflammatory drug use.

Related Experiment Videos

Last Updated: Jun 20, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Surgical Interventions

Background:

  • Selective laser trabeculoplasty (SLT) is a standard treatment for open-angle glaucoma, aiming to reduce intraocular pressure.
  • SLT is generally considered safe with a low complication rate.

Observation:

  • A case study involving a 77-year-old woman with primary open-angle glaucoma is presented.
  • Hyphema (blood in the eye's anterior chamber) was observed three days after undergoing SLT.

Findings:

  • The patient had a history of intermittent oral nonsteroidal anti-inflammatory drug (NSAID) use and chronic topical NSAID use.
  • This NSAID usage is hypothesized as a potential risk factor contributing to the development of hyphema after SLT.

Implications:

  • This case highlights a potential, albeit uncommon, complication of SLT.
  • Clinicians should consider medication history, particularly NSAID use, when assessing risks associated with SLT in glaucoma patients.